WHO ICTRP trial
Assessment of the probiotic symprove as a dietary supplement in patients with…
ISRCTN77512412 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN77512412 |
|---|---|
| Public title | Assessment of the probiotic symprove as a dietary supplement in patients with irritable bowel syndrome |
| Scientific title | Assessment of the probiotic symprove as a dietary supplement in patients with irritable bowel syndrome: a double-blind randomised placebo-controlled trial |
| Primary sponsor | Kings College Hospital (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Irritable bowel syndrome Digestive System Irritable bowel syndrome |
| Interventions | Symprove probiotic dietary supplement (1 ml/kg) or placebo. Following a 1-week run-in period, all patients will receive 12 weeks of treatment (either placebo or active treatment) followed by a further 4-week follow-up. Patient randomisation… |
| Registration date | Mar 12, 2008 |
| Target size | 186 |
| Secondary IDs | 05LG04 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: